1
[1] Bhalani, D. V., Nutan, B., Kumar, A., & Singh Chandel, A. K. (2022). Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics. Biomedicines, 10(9).
2
[2] Kumar, S. V. P., Vishwanath, B. A., & Swapna, D. (2024). Enhancement of solubility and dissolution rate of BCS class II drugs. International Journal of Pharmaceutical Sciences Review and Research, 84(7).
3
[3] Shekaari, H., Zafarani-Moattar, M. T., Mokhtarpour, M., & Faraji, S. (2023). Solubility of hesperidin drug in aqueous biodegradable acidic choline chloride-based deep eutectic solvents. Scientific Reports, 13(1).
4
[4] Swarup, P., & Agrawal, G. P. (2024). Development of hesperidin solid dispersion for improved solubility and dissolution using mannitol and PVP K30 as carriers. Journal of Applied Pharmaceutical Research, 12(6), 192–202.
5
[5] Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2024). Solubilization techniques used for poorly water-soluble drugs. Acta Pharmaceutica Sinica B, 14(11), 4683–4716.
6
[6] Hashmi, A. R., Sekar, M., Zahra, F., Molugulu, N., & Wong, L. S. (2025). Advanced drug delivery strategies to overcome solubility and permeability challenges: Driving biopharmaceutical advancements toward commercial success. ACS Omega, 10(36), 40769–40792.
7
[7] Tekade, A. R., & Yadav, N. J. (2020). A review on solid dispersion and carriers used therein for solubility enhancement of poorly water soluble drugs. Advanced Pharmaceutical Bulletin, 359–369.
8
[8] Pisano, R., & Fissore, D. (2023). New trends in freeze-drying of pharmaceutical products. Pharmaceutics, 15(7).
9
[9] Bessarabov, V., Lisovyi, V., Lyzhniuk, V., Kostiuk, V., Smishko, R., Yaremenko, V., ... & Melnyk, V. (2025). Development and characterisation of polymeric solid dispersed systems of hesperidin, obtained by centrifugal fibre formation. Heliyon, 11(4).
10
[10] Pardeshi, S. R., Deshmukh, N. S., Telange, D. R., Nangare, S. N., Sonar, Y. Y., Lakade, H. S., ... & Sangshetti, J. N. (2023). Process development and quality attributes for the freeze-drying process in pharmaceuticals, biopharmaceuticals and nanomedicine delivery: A state-of-the-art review. Future Journal of Pharmaceutical Sciences, 9(1).
11
[11] Khorasanian, A. S., Fateh, S. T., Gholami, F., Rasaei, N., Gerami, H., Khayyatzadeh, S. S., ... & Asbaghi, O. (2023). The effects of hesperidin supplementation on cardiovascular risk factors in adults: A systematic review and dose–response meta-analysis. Frontiers in Nutrition, 10.
12
[12] Paczkowska-Walendowska, M., Miklaszewski, A., & Cielecka-Piontek, J. (2023). Improving solubility and permeability of hesperidin through electrospun orange-peel-extract-loaded nanofibers. International Journal of Molecular Sciences, 24(9).
13
[13] Gerasimov, A. V., Ziganshin, MA., Gorbatchuk, V. V., & Usmanova, L. S. (2013). Formation of solid dispersion of PEG-1000 with phenacetin according to differential scanning calorimetry. Der Pharma Chemica, 5(4), 133–139.
14
[14] Mundada, A. S. (2021). Solid dispersion: A review. International Journal of Pharmacy Research & Technology, 11(2).
15
[15] Almeida, H., Ferreira, B., Fernandes-Lopes, C., Araújo, F., Bonifacio, M. J., Vasconcelos, T., ... & Soares-da-Silva, P. (2024). Third-generation solid dispersion through lyophilization enhanced oral bioavailability of resveratrol. ACS Pharmacology & Translational Science, 7(3), 888–898.
16
[16] Bessarabov, V., Lisovyi, V., Lyzhniuk, V., Kostiuk, V., Smishko, R., Yaremenko, V., ... & Melnyk, V. (2025). Development and characterisation of polymeric solid dispersion systems of hesperidin obtained by the method of centrifugal fibre formation.
17
[17] Yaghoubi, N., Gholamzad, A., Naji, T., & Gholamzad, M. (2024). In vitro evaluation of PLGA loaded hesperidin on colorectal cancer cell lines: An insight into nano delivery system. BMC Biotechnology, 24(1).
18
[18] Brogly, M., Bistac, S., & Bindel, D. (2024). Adsorption and structuration of PEG thin films: Influence of the substrate chemistry. Polymers, 16(9).
19
[19] Rosiak, N., Wdowiak, K., Tykarska, E., & Cielecka-Piontek, J. (2022). Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases. International Journal of Molecular Sciences, 23(23).
20
[20] Invernizzi, C., Rovetta, T., Licchelli, M., & Malagodi, M. (2018). Mid and near-infrared reflection spectral database of natural organic materials in the cultural heritage field. International Journal of Analytical Chemistry, 2018.
21
[21] Sip, S., Sip, A., Miklaszewski, A., Żarowski, M., & Cielecka-Piontek, J. (2023). Zein as an effective carrier for hesperidin delivery systems with improved prebiotic potential. Molecules, 28(13).
22
[22] Dai, F., Zhuang, Q., Huang, G., Deng, H., & Zhang, X. (2023). Infrared spectrum characteristics and quantification of OH groups in coal. ACS Omega, 8(19), 17064–17076.
23
[23] Campanale, C., Savino, I., Massarelli, C., & Uricchio, V. F. (2023). Fourier transform infrared spectroscopy to assess the degree of alteration of artificially aged and environmentally weathered microplastics. Polymers, 15(4).
24
[24] Patel, K., Shah, S., & Patel, J. (2022). Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review. DARU Journal of Pharmaceutical Sciences, 165–189.
25
[25] De Oliveira Cardoso Melo, M. E., Castro da Silva, C., Dos Santos Dantas, T., Barbosa Machado, JC., Assunção Ferreira, M. R., & Lira Soares, L. A. (2026). Amorphous solid dispersions as a strategy to enhance the bioavailability and stability of formulations containing plant active ingredients: An integrative review. DARU Journal of Pharmaceutical Sciences.
26
[26] Xiao, H., Feng, Y., Goundry, W. R. F., & Karlsson, S. (2024). Organic solvent nanofiltration in pharmaceutical applications. Organic Process Research & Development, 891–923.
27
[27] Rosiak, N., Wdowiak, K., Tykarska, E., & Cielecka-Piontek, J. (2022). Amorphous solid dispersion of hesperidin with polymer excipients for enhanced apparent solubility as a more effective approach to the treatment of civilization diseases. International Journal of Molecular Sciences, 23(23).
28
[28] Bertoni, S., Albertini, B., & Passerini, N. (2023). Investigating the physicochemical properties of solid dispersions based on semicrystalline carriers: A case study with ketoprofen. International Journal of Pharmaceutics, 632.
29
[29] Malkawi, R., Malkawi, W. I., Al-Mahmoud, Y., & Tawalbeh, J. (2022). Current trends on solid dispersions: Past, present, and future. Advances in Pharmacological and Pharmaceutical Sciences, 2022.
30
[30] De Mohac, L. M., Caruana, R., Cavallaro, G., Giammona, G., & Licciardi, M. (2020). Spray-drying, solvent-casting and freeze-drying techniques: A comparative study on their suitability for the enhancement of drug dissolution rates. Pharmaceutical Research, 37(3).
31
[31] Thomas, M., Nabais, A. R., Burggraef, M. J., Peeva, L., Murray, J., & Livingston, A. G. (2025). Enabling High-Boiling-Point Green Solvent Recycling Using Organic Solvent Nanofiltration Membranes. ChemSusChem, 18(21), e202501117.
32
[32] Xie, B., Liu, Y., Li, X., Yang, P., & He, W. (2024). Solubilization techniques used for poorly water-soluble drugs. Acta Pharmaceutica Sinica B, 4683–4716.
33
[33] Le Khanh, H. P., Haimhoffer, Á., Nemes, D., Józsa, L., Vasvári, G., Budai, I., ... & Fenyvesi, F. (2023). Effect of molecular weight on the dissolution profiles of PEG solid dispersions containing ketoprofen. Polymers, 15(7).
34
[34] Jelić, D. (2021). Thermal stability of amorphous solid dispersions. Molecules, 26(1).
35
[35] Joshi, S., Dhingra, A. K., Chopra, B., Dass, R., Guarve, K., & Sapra, S. (2023). Formulation and evaluation of solid dispersions of poorly water-soluble drug-hesperidin. Letters in Applied NanoBioScience, 12(2).
36
[36] Kanaze, F. I., Kokkalou, E., Niopas, I., Georgarakis, M., Stergiou, A., & Bikiaris, D. (2006). Dissolution enhancement of flavonoids by solid dispersion in PVP and PEG matrixes: A comparative study. Journal of Applied Polymer Science, 102(1), 460–471.
37
[37] Akram, A., Irfan, M., Abualsunun, W. A., Bukhary, D. M., & Alissa, M. (2022). How to improve solubility and dissolution of irbesartan by fabricating ternary solid dispersions: Optimization and in-vitro characterization. Pharmaceutics, 14(11).